Kristi Thompson Sues Abbott Laboratories Over Implant

A Georgia woman alleges a defective spinal cord stimulator lead necessitated a removal surgery.

Updated on Oct. 16, 2026 in Healthcare

Bold flat-color editorial illustration showing a stylized electrode cable against a solid background, evoking medical product liability litigation.
Georgia resident Kristi Thompson has filed a product liability lawsuit against Abbott Laboratories in Illinois, alleging a defective spinal cord stimulator lead. AI Illustration. Upload story photo >

Live Poll

Should medical device companies be held legally liable when their implants cause unexpected patient complications?

Kristi Thompson has filed a product liability lawsuit against Abbott Laboratories in the U.S. District Court for the Northern District of Illinois. The complaint claims a defective lead in the plaintiff's spinal cord stimulator migrated, requiring additional surgery to remove the implant.

Why it matters

The lawsuit contends that the manufacturer failed to provide adequate warnings regarding potential failure risks associated with the medical device. This case joins broader litigation involving similar spinal cord stimulation technology from other manufacturers.

The lawsuit filed against Abbott Laboratories represents one of multiple active legal challenges facing manufacturers of spinal cord stimulation devices. Other companies currently involved in similar product liability litigation include Boston Scientific, Nevro, and Medtronic.

The players

Kristi Thompson

She is a Georgia resident who is the plaintiff in the product liability lawsuit against Abbott Laboratories.

Abbott Laboratories

This is a global healthcare company that manufactures medical devices, including the spinal cord stimulator identified in the complaint.

The details

The medical device in question utilizes a battery-powered pulse generator, electrode leads, and an external remote control for pain management. The plaintiff alleges that sales representatives previously managed stimulation settings to adjust the device's therapeutic output.

Timeline

  1. October 12, 2026: Kristi Thompson filed the lawsuit in federal court.

Market Landscape

This case highlights the growing legal risks associated with medical device manufacturing, particularly as companies navigate complex product liability claims. It positions Abbott Laboratories alongside major competitors who are currently managing similar challenges within the spinal cord stimulation sector.

Patients who use spinal cord stimulation devices may face increased scrutiny regarding the potential risks and maintenance of their implants. This litigation could influence how manufacturers disclose failure risks and how clinical representatives communicate device settings to users.

The takeaway

Patients experiencing complications with implanted medical devices should consult their physicians to discuss specific symptoms and potential risks. Maintaining clear communication with medical providers regarding device settings and performance remains an essential practice for those using long-term implants.

Further reading

For more context on medical device litigation, visit the United States Healthcare section.

Source note: This article includes information reported by AboutLawsuits.

Live Poll

Should medical device companies be held legally liable when their implants cause unexpected patient complications?